1026 related articles for article (PubMed ID: 26649589)
41. Value of sentinel lymph node biopsy in breast cancer surgery with simple pathology facilities--an Iranian local experience with a review of potential causes of false negative results.
Amoui M; Akbari ME; Tajeddini A; Nafisi N; Raziei G; Modares SM; Hashemi M
Asian Pac J Cancer Prev; 2012; 13(11):5385-9. PubMed ID: 23317188
[TBL] [Abstract][Full Text] [Related]
42. Achieving breast cancer surgery in a single setting with intraoperative frozen section analysis of the sentinel lymph node.
Lu Q; Tan EY; Ho B; Teo C; Seah MD; Chen JJ; Chan PM
Clin Breast Cancer; 2013 Apr; 13(2):140-5. PubMed ID: 23218472
[TBL] [Abstract][Full Text] [Related]
43. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer.
Hino M; Sano M; Sato N; Homma K
Surg Today; 2008; 38(7):585-91. PubMed ID: 18612781
[TBL] [Abstract][Full Text] [Related]
44. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
45. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
[TBL] [Abstract][Full Text] [Related]
46. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
[TBL] [Abstract][Full Text] [Related]
47. Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node.
Meattini I; Saieva C; Bertocci S; Francolini G; Zei G; De Luca Cardillo C; Scotti V; Greto D; Bonomo P; Orzalesi L; Bianchi S; Livi L
Tumori; 2015; 101(1):78-83. PubMed ID: 25702658
[TBL] [Abstract][Full Text] [Related]
48. Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study.
Yang X; Li Y; Ren XT; Fan L; Hua B
World J Surg Oncol; 2023 Jul; 21(1):214. PubMed ID: 37480099
[TBL] [Abstract][Full Text] [Related]
49. Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results?
Alarcón M; Buch E; Julve A; Hernandorena M; Tajahuerce M; Rodríguez H; Bermejo B; Ramírez J; Burgués O; Díaz S; Alcalá GM; Ortega J
Surgeon; 2021 Dec; 19(6):344-350. PubMed ID: 33663946
[TBL] [Abstract][Full Text] [Related]
50. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
51. The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis.
van Nijnatten TJ; Schipper RJ; Lobbes MB; Nelemans PJ; Beets-Tan RG; Smidt ML
Eur J Surg Oncol; 2015 Oct; 41(10):1278-87. PubMed ID: 26329781
[TBL] [Abstract][Full Text] [Related]
52. Association of the number of sentinel lymph nodes harvested with survival in breast cancer.
Bonneau C; Bendifallah S; Reyal F; Rossi L; Rouzier R
Eur J Surg Oncol; 2015 Jan; 41(1):52-8. PubMed ID: 25466979
[TBL] [Abstract][Full Text] [Related]
53. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
[TBL] [Abstract][Full Text] [Related]
54. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
55. Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.
Wu S; Wang Y; Zhang N; Li J; Xu X; Shen J; Liu G
Ann Surg Oncol; 2018 Oct; 25(11):3150-3157. PubMed ID: 30083833
[TBL] [Abstract][Full Text] [Related]
56. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
57. Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
Chen M; Li S; Huang M; Guo J; Huang X; Guo W; Chen L; Lin Y; Jacobs L; Wang C; Fu F
Breast Cancer Res Treat; 2022 Nov; 196(2):267-277. PubMed ID: 36100784
[TBL] [Abstract][Full Text] [Related]
58. Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
Costarelli L; Arienzo F; Broglia L; La Pinta M; Scavina P; Meli EZ; Colavito MH; Ascarelli A; Campagna D; Mastropietro T; Manna E; Amato M; Andrulli AD; Schiavone A; Minelli M; Fortunato L
Ann Surg Oncol; 2024 May; 31(5):3186-3193. PubMed ID: 38427160
[TBL] [Abstract][Full Text] [Related]
59. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
[TBL] [Abstract][Full Text] [Related]
60. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
